Browsed by
Category: Immune system

Crohn’s Disease: The Hidden Gut Disorder You Should Never Ignore

Crohn’s Disease: The Hidden Gut Disorder You Should Never Ignore

Crohn’s disease is a chronic inflammatory condition that affects the digestive tract and can significantly impact quality of life. As a form of Inflammatory Bowel Disease, it often develops silently, with symptoms that may be mistaken for common digestive issues. However, without proper management, it can lead to serious complications.

This blog explores the symptoms, causes, treatment options, and lifestyle strategies to help you better understand and manage Crohn’s Disease.


What Is Crohn’s Disease?

https://images.openai.com/static-rsc-4/v3tUNaHGh7EZczpSSgaeQ_nOB57wLLVYc-pgFp1jZyOYe59bJ6sF9rFGRkWzibkMtMyfBOsJZuz569BLr51skCIypMKE6O9WkxgdFWN9iAMoQUGvYsf3PhOj_Or4a2RM33f3NICmVloxPW4kh616bpLkoZNOPvuzZHnHzONZKmCr9IZFQe6UdlBMJxGyonOG?purpose=fullsize

Crohn’s disease is a long-term condition that causes inflammation anywhere along the gastrointestinal (GI) tract—from the mouth to the anus. It most commonly affects the small intestine and the beginning of the large intestine.

Unlike some other digestive disorders, Crohn’s disease inflammation can penetrate deeply into the layers of bowel tissue, leading to pain and complications.


Common Symptoms to Watch For

https://images.openai.com/static-rsc-4/VGDG1et5NlOQYLC9Prq8-EC61rBICCq0S73x0sauvw5wnF8PJmQB7Z-RCZ8fPF3jS6FGLaIDeh8Q-Qq6P39NGQ3A5YmdA3uI_FTKsUC87byYa5-EcFlmt3H3hZdWzAJpW0TtTHf3bMWdtPWX7OcS5schxg57uvV-CH78hoOBGeKty9UZtUF1gc3jcztAtX_h?purpose=fullsize

Symptoms can vary from mild to severe and may come and go. Common signs include:

  • Persistent diarrhea
  • Abdominal pain and cramping
  • Fatigue and low energy
  • Unintended weight loss
  • Blood in the stool
  • Reduced appetite

In severe cases, complications like fistulas, ulcers, and bowel obstruction may occur.


What Causes Crohn’s Disease?

https://images.openai.com/static-rsc-4/rVZh98Z9NUZ7di1iyuyvcLU2afPHaWNkaUOadlUHtSaL8GQyKa-VF9R1Qgx8QPl6gSut2dcg0tyjfoZMf_a_ByWiniMeeZSvHTsFg8S42rOtACX_NVmfuthRlN5IAzwFYdIAxH7NxqGLul4ytHfTg3R6MxbY13V5pJOeil9ivYeNHYffoWCn1gvCzNn_MGuw?purpose=fullsize

The exact cause of Crohn’s disease is still unknown, but several factors are believed to contribute:

🧬 1. Immune System Dysfunction

An abnormal immune response may cause the body to attack its own digestive tract.

🧬 2. Genetics

A family history of IBD increases your risk.

🧬 3. Environmental Factors

Smoking, stress, diet, and infections may trigger or worsen symptoms.


Potential Complications

https://images.openai.com/static-rsc-4/ELvPYNOTT6UQW0W9GwFr8O52rGci8MNUi4j5cb5Es4IUkofZd983LUAozeyCjT6b8HVZZFyHmJy53hSUOJD7-5rznUctS9fe2Hjm6k7KIbc2FoRl6qG_SUCukU4dY-VBxEW95pLsJ8bOrTFCt7KUTc8Uo4WD23uw7FnOplSak2B5PW1a96kXCMPIZImPDcGD?purpose=fullsize

If left untreated, Crohn’s disease can lead to:

  • Bowel obstruction
  • Ulcers and fistulas
  • Malnutrition due to poor nutrient absorption
  • Increased risk of Colon Cancer
  • Severe inflammation requiring surgery

Treatment Options

https://images.openai.com/static-rsc-4/SNK2QxlFwRAtY5iucNTr-TwY04uXdRqnLInwFmgs4n6F51l8hSZaOZIUNc96Xmalb94ZtjFr_ZIHPZWKckj_XNiohRqdZ9b2YCaNM1LZ87RzisbRYTq6U_8hAnyuUKsTxuDXxYNHCAtVSmptfmo_xBlxaFGzsxbZjfFT31t9SBuXKxCnIII2ZLtX-ywj9fPT?purpose=fullsize
https://images.openai.com/static-rsc-4/zMCXbRzXSvTOSSXYerZBEZuXReGcYlSfBVAC6K2N2LIqHLREKhYVNLVy5DmZ9-5mCbd6AP7kn0BMPZ3SmmhsEY6VB3EXYLgWdKXaUTfa6HhllrNj0vkufYVBtebHoMVwfbjUzmMremW38pMz-RtWJeMG-hMJSLgHp3PWjqqzIkjSziPtJ2e9tYcxhcZRE0wj?purpose=fullsize

While there is no cure, treatment focuses on reducing inflammation and managing symptoms.

💊 Medications

  • Anti-inflammatory drugs
  • Immune system suppressors
  • Biologic therapies targeting specific immune responses

🥗 Dietary Changes

  • Avoid trigger foods (spicy, fatty, dairy for some patients)
  • Eat smaller, more frequent meals
  • Stay hydrated

🏥 Surgery

In severe cases, damaged portions of the digestive tract may need to be removed.


Lifestyle Tips for Managing Crohn’s

https://images.openai.com/static-rsc-4/X9YFPPx9wnKdGj_OU9m7E2RIkjaMe4ZG9KRyU3m2bE4_mbtNNAnhLUlbBeLzoKiIKataVMb25V04gFZX4QqqPDCRwQouzVEdFSxMp5-X4cbj7NoX9ZU0r2xBSWt-Yhe5042TroNWdi1sJF6bzpWrh2x6nq23tp3DB5I3rS6OSiZ7Q9BNqX4FGW4MBkrunJfu?purpose=fullsize

Living with Crohn’s disease requires long-term care and lifestyle adjustments:

  • Manage stress through meditation or yoga
  • Quit smoking to reduce flare-ups
  • Keep a food diary to identify triggers
  • Stay consistent with medications and doctor visits

When to See a Doctor

Seek medical attention if you experience:

  • Persistent diarrhea lasting more than a few days
  • Severe abdominal pain
  • Blood in stool
  • Sudden weight loss or fatigue

Early diagnosis can help prevent complications and improve outcomes.


Final Thoughts

Crohn’s Disease may be a lifelong condition, but with the right treatment and lifestyle changes, many people live full and active lives. Awareness is the first step—don’t ignore the warning signs your gut may be giving you.


📚 References

  1. Mayo Clinic – Crohn’s Disease: Symptoms & Causes
  2. World Health Organization – Digestive Health and Chronic Diseases
  3. https://my.clevelandclinic.org/health/diseases/21214-coronavirus-covid-19

Medications that have been suggested by doctors worldwide are available on the link below
https://blog.mygenericpharmacy.com/index.php/category/inflammation/

Rapamycin and Life Extension: Miracle Molecule or Medical Myth?

Rapamycin and Life Extension: Miracle Molecule or Medical Myth?

Introduction: The Easter Island Secret

In the 1970s, a team of scientists traveled to Easter Island—known to its inhabitants as Rapanui—to collect soil samples. What they found would spark one of the most intriguing debates in modern medicine: a bacterium called Streptomyces hygroscopicus producing a compound with remarkable properties. They named it rapamycin, after the island’s native name.

Fast forward five decades, and rapamycin has become the subject of intense scientific and public fascination. Lab studies show it extends the lifespan of mice by up to 25%. Biohackers and longevity clinics are already taking it off-label. But is rapamycin truly a fountain of youth hiding in plain sight, or are we getting ahead of the evidence?

What Is Rapamycin? A Drug with Many Faces

Rapamycin, also known by its generic name sirolimus, is not a new drug. It has been FDA-approved for over two decades for specific medical uses:

The drug works by inhibiting a cellular pathway called mTOR (mechanistic target of rapamycin). Think of mTOR as a master switch inside your cells that senses nutrient availability and regulates growth, metabolism, and aging. When nutrients are abundant, mTOR tells cells to grow and divide. When inhibited—either by rapamycin or by caloric restriction—cells shift into maintenance mode, ramping up a cleanup process called autophagy that removes damaged components.

The Animal Evidence: Why Excitement Is Justified

The case for rapamycin as a longevity drug rests on remarkably consistent animal data. In the landmark Intervention Testing Program (ITP) funded by the National Institute on Aging, rapamycin was one of the few compounds that consistently extended lifespan in genetically diverse mice—in both sexes, across multiple sites, and even when started late in life .

Beyond basic lifespan extension, animal studies have demonstrated:

BenefitObserved Effect
Lifespan extensionUp to 25% increase in median and maximum lifespan
Cardiovascular functionImproved heart and blood vessel health in aged animals
Immune functionEnhanced response to vaccination, reduced infections
Cancer preventionDelayed onset of age-related cancers
Inflammation reductionLower levels of pro-inflammatory cytokines 

A 2025 study published in Nature Aging even showed that combining rapamycin with another drug (trametinib) produced additive effects, further extending healthspan and reducing inflammation across multiple organs in mice 

The Human Evidence: What We Actually Know

Here’s where the story gets complicated. Despite decades of animal research, high-quality human data on rapamycin for healthy aging isareurprisingly limited 

Promising Signals

Several small studies have reported encouraging findings:

Cardiovascular Health:
A 2025 pilot study gave 1 mg of rapamycin daily for 8 weeks to healthy men aged 70-76. Results showed statistically significant improvements in cardiac function (transmitral blood flow, peak flow rate) and endothelial function, the inner lining of blood vessels that tends to decline with age .

Immune Function:
Studies using everolimus (a rapamycin analog) found that low-dose treatment enhanced immune response to influenza vaccination in older adults, with a 20% increase in antibody titers. Participants also experienced fewer respiratory infections .

Self-Reported Benefits:
A 2023 survey of 333 individuals taking rapamycin off-label reported:

  • Lower likelihood of COVID-19 infection and long COVID
  • Improved well-being, happiness, and brain function
  • Reduced abdominal pain, depression, and anxiety 

However, the authors caution that this study was not blinded and may reflect placebo effects .

The Caveats: Where Evidence Falls Short

Despite these signals, no study has yet demonstrated that rapamycin extends human lifespan or clearly slows biological aging. A comprehensive 2025 review in the journal Aging concluded: “The clinical evidence of benefit associated with low-dose rapamycin use in healthy human adults has not been established.” 

Key limitations include:

  • Small sample sizes (most trials involve dozens, not thousands)
  • Short duration (weeks to months, not years)
  • Surrogate endpoints (biomarkers, not mortality)
  • Lack of placebo controls in many studies
  • No standardized dosing (regimens vary wildly)

One analysis using the PhenoAge model suggested rapamycin users might have reduced biological age by nearly four years—but this was based on averaged data, not individual measurements .

Potential Side Effects: The Other Side of the Molecule

Rapamycin is not a benign supplement. Its FDA-approved uses carry significant warnings, and even at low doses, concerning signals emerge:

Side EffectObservations
Metabolic changesIncreased triglycerides, HbA1C, and VLDL in some studies 
Mouth ulcersBenign aphthous ulcers were significantly more common in treatment arms 
Muscle protein synthesisMay blunt post-exercise muscle building (conflicting data) 
AnxietySome participants reported increased anxiety and noradrenaline levels 
Immune suppressionHigher doses cause immunosuppression—the “threshold” effect matters 

The drug’s narrow therapeutic window means that too little may be ineffective, while too much triggers the very immunosuppression that transplant patients experience.

Off-Label Use: The Biohacker Movement

None of this has stopped a growing community from experimenting. Longevity clinics now prescribe rapamycin off-label, and online forums buzz with personal protocols. The drug is generic and inexpensive, creating little incentive for pharmaceutical companies to fund expensive definitive trials.

But off-label is not the same as evidence-based. A 2025 review in Frontiers in Aging noted that physicians and “biohackers” are using mTOR inhibition off-label, despite not being widely recognized as a treatment by the broader clinical community.

The Verdict: Miracle or Myth?

So where does this leave us? Let’s weigh the evidence:

The Case FOR Rapamycin

  • Animal data is exceptionally strong—multiple species, replicated studies
  • Mechanism makes sense biologically—mTOR sits at the center of aging pathways
  • Human studies show promising signals in cardiovascular and immune function
  • Short-term safety appears reasonable at low doses in healthy adults

The Case AGAINST

  • No direct human lifespan data exists
  • Long-term safety is unknown—we’re talking about taking this for decades
  • Side effects are real and may outweigh benefits for healthy individuals
  • Evidence quality is low—small, short, unblinded studies

The most balanced conclusion comes from the 2025 review: “What emerges is a complex picture that remains insufficient to affirm or negate the longevity and healthspan extending benefits attributed to rapamycin”.

Practical Considerations: If You’re Still Curious

For those considering rapamycin despite the uncertainty, experts recommend:

  1. Work with a knowledgeable physician—this is not a DIY supplement
  2. Get baseline measurements—lipids, HbA1C, inflammatory markers
  3. Start low, go slow—the “threshold” effect matters
  4. Monitor regularly—repeat labs to catch metabolic changes
  5. Be realistic—this is experimental, not proven

The Future: What’s Next

Research is accelerating. Ongoing studies are exploring:

  • Intermittent dosing (weekly instead of daily) to reduce side effects
  • Combination therapies (like rapamycin + trametinib) 
  • Better biomarkers to identify who responds
  • Next-generation mTOR inhibitors with fewer off-target effects

As one expert puts it: “The next frontier is understanding why someone ages the way they do and how it’s expressed”. Personalized approaches may eventually identify those most likely to benefit.

Conclusion: Hope with Humility

Rapamycin represents one of the most promising molecules in the history of aging research—but promise is not proof. The gap between robust animal data and limited human evidence remains wide.

Is rapamycin a miracle molecule? Not yet proven. A medical myth? No—the science is real, just incomplete.

For now, the most honest answer is that rapamycin sits in a scientific limbo: too promising to dismiss, too unproven to recommend widely. As research continues, we may finally learn whether this Easter Island microbe holds the key to longer, healthier lives—or whether the hype outpaced the evidence.

One thing is certain: the pursuit itself is teaching us more about aging than we ever imagined possible.


References:

https://www.sciencedirect.com/science/article/pii/S0531556523000876
https://pmc.ncbi.nlm.nih.gov/articles/PMC3796212/
https://www.nad.com/news/anti-aging-drug-rapamycin-extends-life-as-much-as-dieting-new-study-shows
https://www.aging-us.com/news-room/rapamycin-shows-limited-evidence-for-longevity-benefits-in-healthy-adults

Medications that have been suggested by doctors worldwide are available on the link below
https://mygenericpharmacy.com/category/disease/immunotherapy/rapamune


Disclaimer: This article is for educational purposes only. Rapamycin is an FDA-approved prescription medication with significant side effects and drug interactions. Consult a qualified healthcare provider before considering any off-label use.

Immunotherapy Revolution: Harnessing the Body’s Defense System to Fight Disease

Immunotherapy Revolution: Harnessing the Body’s Defense System to Fight Disease

A Paradigm Shift in Medicine

Immunotherapy represents a groundbreaking frontier in medical science—a treatment approach that doesn’t directly target diseases but instead empowers the body’s own immune system to combat them. While traditional therapies like chemotherapy attack both healthy and diseased cells, immunotherapy specifically trains, enhances, or redirects our natural defenses. This approach has revolutionized cancer treatment and holds transformative promise for autoimmune disorders, infectious diseases, and even neurodegenerative conditions. The 2018 Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo for their discoveries in cancer immunotherapy underscores its monumental importance.

The Immune System: A Complex Defense Network

To understand immunotherapy, we must first appreciate the immune system’s sophisticated architecture:

Innate Immunity: Our rapid-response first line of defense including physical barriers (skin), phagocytes (neutrophils, macrophages), and natural killer (NK) cells.

Adaptive Immunity: The specialized, learned response involving:

  • T-cells: Orchestrate immune responses; include cytotoxic T-cells (CD8+) that kill infected/cancerous cells, and helper T-cells (CD4+) that direct the immune orchestra.
  • B-cells: Produce antibodies that neutralize pathogens.
  • Memory cells: Provide long-term immunity.

Immune Checkpoints: Crucial regulatory molecules (like PD-1, CTLA-4) that prevent excessive immune responses and autoimmunity—a mechanism cancers exploit to evade detection.

The Cancer-Immunity Cycle: Where Immunotherapy Intervenes

Cancer develops when malignant cells evade immune surveillance. The cancer-immunity cycle describes the seven-step process required for an effective anti-tumor response [2]:

  1. Release of cancer cell antigens
  2. Antigen presentation by dendritic cells
  3. Priming and activation of T-cells
  4. Trafficking of T-cells to tumors
  5. Infiltration into the tumor microenvironment
  6. Recognition of cancer cells by T-cells
  7. Killing of cancer cells

Each step presents a potential therapeutic target. Immunotherapy works by removing barriers and amplifying signals along this cycle.

Types of Immunotherapy: The Therapeutic Arsenal

1. Immune Checkpoint Inhibitors (The Game-Changers)

These drugs block proteins that act as immune system “brakes,” unleashing T-cells to attack cancer.

PD-1/PD-L1 Inhibitors:

  • Mechanism: Programmed Death-1 (PD-1) on T-cells binds to PD-L1 on cancer cells, signaling “don’t attack me.” Blocking this interaction removes the disguise.
  • Drugs: Pembrolizumab (Keytruda), nivolumab (Opdivo), atezolizumab (Tecentriq).
  • Success story: Transformed advanced melanoma (5-year survival increased from 5% to 52% with ipilimumab+nivolumab) [3].

CTLA-4 Inhibitors:

  • Mechanism: Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) regulates early T-cell activation.
  • Drug: Ipilimumab (Yervoy).
  • Notable: First checkpoint inhibitor approved (2011 for melanoma).

2. CAR T-Cell Therapy: Living Drugs

Chimeric Antigen Receptor (CAR) T-cell therapy genetically engineers a patient’s own T-cells to recognize and destroy cancer.

Process:

  1. Leukapheresis: Collect patient T-cells.
  2. Genetic engineering: Insert CAR gene targeting a tumor antigen (e.g., CD19 for B-cell cancers).
  3. Expansion: Grow millions of CAR T-cells.
  4. Lymphodepleting chemotherapy: Clear space in immune system.
  5. Infusion: Return “supercharged” T-cells to patient.

Approved therapies: Tisagenlecleucel (Kymriah) for leukemia/lymphoma, axicabtagene ciloleucel (Yescarta).

Remarkable results: 80-90% complete remission in refractory B-cell ALL [4].

3. Cancer Vaccines

Unlike preventive vaccines, therapeutic cancer vaccines train the immune system to recognize tumor-specific antigens.

Types:

  • Dendritic cell vaccines: Sipuleucel-T (Provenge) for prostate cancer—first FDA-approved cancer vaccine (2010).
  • Neoantigen vaccines: Personalized vaccines targeting patient-specific tumor mutations.
  • Virus-based vaccines: Talimogene laherparepvec (T-VEC) uses modified herpes virus to infect melanoma cells, triggering immune response.

4. Monoclonal Antibodies

Lab-created antibodies that either:

  • Mark cancer cells for immune destruction (rituximab targets CD20 on lymphoma cells).
  • Deliver toxins/radiation directly to tumors (antibody-drug conjugates like ado-trastuzumab emtansine for HER2+ breast cancer).

5. Cytokines: Immune System Messengers

Proteins that regulate immune cell activity:

  • Interleukin-2 (IL-2): For metastatic melanoma/renal cancer (limited by toxicity).
  • Interferon-alpha: Historical use in melanoma, now largely supplanted.
  • Newer cytokines: Engineered versions with improved safety profiles.

6. Oncolytic Virus Therapy

Genetically modified viruses that selectively infect and kill cancer cells while stimulating immune responses. T-VEC (mentioned above) is the first FDA-approved oncolytic virus.

Beyond Cancer: Immunotherapy’s Expanding Horizons

Autoimmune Diseases

Paradoxically, here the goal is to suppress overactive immune responses:

  • Checkpoint agonists: Activate inhibitory pathways (experimental for lupus, rheumatoid arthritis).
  • Treg (regulatory T-cell) therapy: Expand these “peacekeeper” cells.
  • B-cell depletion: Rituximab for rheumatoid arthritis, lupus.

Infectious Diseases

  • HIV: Broadly neutralizing antibodies in clinical trials.
  • COVID-19: Monoclonal antibodies (bamlanivimab, REGEN-COV) for prevention/treatment.

Neurodegenerative Diseases

Early research using antibodies to clear pathological proteins:

Transplant Medicine

Treg therapy to promote transplant tolerance, reducing need for lifelong immunosuppression.

The Challenges and Limitations

Response Heterogeneity

Immunotherapy doesn’t work for everyone. Biomarkers help predict response:

  • Tumor mutational burden (TMB): Higher mutations → more neoantigens → better response.
  • PD-L1 expression: Higher expression often predicts checkpoint inhibitor response.
  • Mismatch repair deficiency (dMMR): Predicts pembrolizumab response across cancers.

Immune-Related Adverse Events (irAEs)

Unleashing the immune system can cause autoimmunity-like side effects affecting any organ:

  • Colitis: Diarrhea, abdominal pain (most common with CTLA-4 inhibitors).
  • Pneumonitis: Cough, shortness of breath.
  • Endocrinopathies: Thyroiditis, hypophysitis, diabetes.
  • Dermatitis: Rash, pruritus.
  • Hepatitis, nephritis, myocarditis.

Management: High-dose corticosteroids, other immunosuppressants, treatment interruption/discontinuation.

Resistance Mechanisms

Tumors develop resistance through:

  • Loss of antigen presentation.
  • Upregulation of alternative checkpoints.
  • Creating immunosuppressive tumor microenvironment.
  • T-cell exhaustion.

Logistical and Financial Barriers

  • CAR T-cell therapy: Complex manufacturing, “vein-to-vein” time ~3 weeks, cost ~$400,000.
  • Checkpoint inhibitors: $100,000-$150,000/year.
  • Access disparities: Limited to major academic centers, insurance barriers.

The Future Frontier: Next-Generation Immunotherapies

Novel Targets

  • TIM-3, LAG-3, TIGIT: Next-generation checkpoint inhibitors.
  • CD47: “Don’t eat me” signal on cancer cells; magrolimab blocks it, enhancing phagocytosis.

Combination Strategies

  • Immunotherapy + targeted therapy: BRAF/MEK inhibitors + checkpoint inhibitors in melanoma.
  • Immunotherapy + chemotherapy: Synergistic effect (pembrolizumab+chemotherapy in lung cancer).
  • Dual checkpoint blockade: CTLA-4 + PD-1 inhibitors (increased efficacy but also toxicity).

Technological Innovations

  • Off-the-shelf CAR T-cells: From healthy donors (allogeneic), avoiding manufacturing delays.
  • CAR NK cells: Natural killer cells with CARs—potentially safer.
  • Bi-specific T-cell engagers (BiTEs): Antibodies connecting T-cells to cancer cells (blinatumomab for ALL).
  • TCR therapy: T-cell receptors engineered to recognize intracellular antigens (broader than CARs).

Personalized Approaches

  • Neoantigen vaccines: Tailored to patient’s tumor mutation profile.
  • Tumor-infiltrating lymphocyte (TIL) therapy: Expand naturally occurring tumor-fighting T-cells.

Patient Experience and Practical Considerations

Treatment Journey

  • Pretesting: Biomarker analysis (PD-L1, TMB, MSI), organ function tests.
  • Administration: Most immunotherapies are IV infusions every 2-6 weeks.
  • Monitoring: Regular imaging (CT/PET scans), blood tests, vigilance for irAEs.
  • Response patterns:
    • Hyperprogression: Rare rapid worsening.
    • Pseudoprogression: Apparent tumor growth from immune infiltration before shrinkage.
    • Delayed response: Can occur months after starting.

Lifestyle and Support

  • Diet/exercise: Emerging evidence supports Mediterranean diet, regular activity.
  • Microbiome: Gut bacteria may influence response (fecal microbiota transplantation trials ongoing).
  • Support networks: Critical for navigating complex treatment and side effects.

Conclusion: A Transformative Era in Medicine

Immunotherapy has fundamentally altered the therapeutic landscape, particularly in oncology, offering durable responses and even cures in previously untreatable advanced cancers. Beyond remarkable clinical successes, it represents a conceptual revolution—viewing disease not just as something to attack, but as a failure of natural defenses that can be corrected.

The field is advancing at breathtaking speed, with over 3,000 immunotherapy clinical trials currently active worldwide. Challenges remain—improving response rates, managing toxicities, reducing costs, and expanding access—yet the trajectory is unmistakably toward increasingly sophisticated, personalized, and effective immune-based treatments.

As we decode more complexities of immune regulation, immunotherapy promises to extend its reach across medicine, offering hope for conditions once considered intractable. This is more than a new class of drugs—it’s a new paradigm for healing, harnessing the most sophisticated defense system ever evolved: our own immunity.


References:
https://my.clevelandclinic.org/health/body/21196-immune-system
https://www.sciencedirect.com/science/article/pii/S1074761313002963
https://www.cancerresearch.org/immunotherapy-by-treatment-types
https://pmc.ncbi.nlm.nih.gov/articles/PMC12061710/

Medications that have been suggested by doctors worldwide are available on the link below
https://mygenericpharmacy.com/category/products/disease/parkinsons-disease

Lets explore the ‘immunity’ secret to living to 100

Lets explore the ‘immunity’ secret to living to 100

The number of persons who reach their 100th birthday or older has increased along with the average lifespan of humans.

Researchers have discovered that centenarians have a distinct immune cell composition and activity, providing them an immune system that prolongs their lives. These discoveries, according to scientists, may be exploited to create treatments for healthy ageing.

Since 1900, the average human life expectancy has more than doubled. The average lifespan across the globe has increased from 31 years in 1900 to 73.2 years in 2023, and is predicted to reach 77.1 years in 2050.

The proportion of individuals who live to be at least 100 years old is also rising. Researchers predict that by 2050, there will be 3.7 million centenarians, who are known as centenarians, with an estimated 450,000 centenarians worldwide in 2015.

Globally, the number of individuals living to be 100 years or older was predicted to more than quintuple between 2005 and 2030, according to earlier data from the early 2000s. What makes some people able to live beyond their 100s while others cannot is one thing that is still unknown.

This question is being addressed by a recent study that was conducted under the direction of scientists from Tufts Medical Center and Boston University Sachool of Medicine and discovered that centenarians have a distinct immune cell composition and activity that allows them to have a highly functional immune system and live longer.

These results, according to scientists, may be utilised to create treatments that promote healthy ageing. In the most recent issue of Lancet eBioMedicine, the study was published.

Immune system as we age

All bodily systems, including the immune system, undergo changes as we become older.

There are two basic theories on how the immune system changes as we age, according to Dr. Scott Kaiser, a geriatrician and the director of Geriatric Cognitive Health for the Pacific Neuroscience Institute in Santa Monica, California.

The first is immunosenescence, which he defined as an age-related immunological malfunctioning process. Hence, ageing can cause a decline in immune function due to changes in the makeup and operation of our immune systems. And that’s strongly tied to how susceptible people are to infections, autoimmune conditions, and even different kinds of cancer, he added.

“And then there’s the problem of inflammaging, which is a term that’s been used to characterise age-related increases in inflammation as a result of high levels of pro-inflammatory markers in the blood and other bodily tissues. For example, neurological disorders like Alzheimer’s disease are strongly associated with that risk factor, according to Dr. Kaiser.

There is a lot to consider regarding immune function over time, he continued, and how our immune systems alter with age may either increase our vulnerability or provide protection for us.

A look at a “exceptional” immunity

For this work, blood samples from seven centenarians enrolled in the New England Centenarian Project were used to perform single-cell sequencing on an immune cell subset known as peripheral blood mononuclear cells (PBMCs).

“We examined immune cells that pass through the immune system throughout the human lifespan using single-cell data and novel computational techniques. We examined the existence of particular immune cell types in younger ages and extreme old age and discovered cell type-specific alterations in ageing and extreme old age, according to Dr. Karagiannis.

We also used the same cell types to investigate how gene expression varies with age in order to identify distinct gene expression patterns of extreme longevity that fluctuate with age but are also specific to the very elderly.

Species-specific cell types in centenarians

After investigation, the researchers validated findings from earlier studies on ageing that pointed to distinct compositional and transcriptional alterations for each cell type that are only observed in centenarians and suggest a healthy immune response.

Also, they discovered that both genes with age-related alterations and genes expressed exclusively in centenarians showed cell type signatures unique to remarkable longevity in centenarians.

“Given that centenarians are an ageing population, we weren’t as shocked to uncover genes that change with age in them. What was unexpected were the varied ageing patterns we discovered, including aging-specific genes whose expression levels changed with advancing age but not in extreme longevity across distinct cell populations, according to Dr. Karagiannis

“Our findings can serve as a platform for further research into the causes of extreme old age, which may result in the development of therapies for healthy ageing. To better understand the protective factors of extreme longevity that contribute to the positive health outcomes seen in these people, we would like to examine longitudinal changes in immune cells of centenarians and younger aged persons.

Innovative treatments for disorders associated with ageing

After reading this study, Dr. Kaiser stated that he thought it was interesting because it examined individuals who had aged remarkably well—individuals who had essentially resisted aging—and then examined what was happening in them to see if there was anything we could learn from them.

The possible lessons from this, he said, “are in what makes us more resilient.”

“Looking at these people who had extreme longevity, living into their 100s and even beyond, and determining what is the nature, what is the characteristic of their immune system so that we could better understand what may be going on, and then determining how that could be translated into potential therapies for other people, so that more people can enjoy that”, said  Doctor Kaiser

We also discussed this study with Kathleen Cameron, senior director of the Institute for Healthy Aging at the National Council on Aging.

In order to help individuals live longer, she said it’s critical to comprehend the immunological changes related to ageing. And many individuals desire to live longer if it means maintaining their health.

“Treatments that extend life may be developed if we can identify what causes this immunological resilience in those who live to be over 100. Nevertheless, it would also be helpful if there were certain healthy habits that contributed to this resilience, Cameron continued.

She did, however, note that this is all very preliminary data and that further research should be done to help medical professionals comprehend this immunological resilience.

REFERENCES:

For Immune health medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=77_328

Common sweetener in high doses may suppress immune system.

Common sweetener in high doses may suppress immune system.

According to a recent study, sucralose, an artificial sweetener, lowers immunological responses in mice when given in large amounts. In particular, it lessens their T cells’ level of activation. Researchers emphasise that sucralose ingestion by humans in usual amounts is unlikely to be detrimental.

Researchers plan to investigate if this popular sweetener could be utilised to calm down overactive immune systems in the future in high doses.

Sucralose, which goes by the brand name Splenda, is one of several artificial sweeteners that have been given the go-ahead for usage in the US. The sugar substitute has 600 times more sweetness than regular sugar.

Sucralose was given the go-ahead by the US Food and Drug Administration in 1999 to be used as a general-purpose sweetener for food.

In order to better understand how nutrition affects disease, Dr. Karen Vousden’s team at the Francis Crick Institute in London decided to study sucralose. She is a specialist in cancer biology.

“Sweetener consumption is rising quickly around the world, and comprehensive research by numerous regulatory bodies have demonstrated that they are safe at levels of usual consumption,” she said.

There have been reports in recent years suggesting that sweeteners may have more impacts than previously believed, including an impact on the gut flora. Hence, we conducted a study to examine these sweeteners’ impact on mice. Karen Vousden, Ph.D.

They recently had a publication about their study appear in Nature. It indicates the scientists discovered that sucralose lowers mice’s immune systems when taken in large dosages.

Recommended sucralose consumption

Sucralose has an acceptable daily intake (ADI) of 5 milligrammes per kilogramme of body weight per day, as set by the FDA. It has an ADI set by the European Food Safety Authority (EFSA) of 15 mg per kg of body weight per day.

Sucralose amounts to 12 milligrammes every packet of Splenda. In the United States, a person weighing 150 pounds can consume 340 mg of sucralose per day and still meet the ADI.

The researchers provided mice with access to water that was comparable to the ADI suggested by the EFSA (.72 mg) and the FDA for rodents for the experiments they conducted for their study (.17 mg).

Higher doses of sucralose

In order to examine the potential impact of sucralose on the immune system, the researchers conducted a number of laboratory tests on the T cells, a subset of white blood cells, of mice and people.

In one experiment, scientists fed mice either 0.17 or 0.72 mg of sucralose or sodium saccharin, a chemically unrelated sweetener (NaS). For several cell types, neither the amount of sucralose nor the presence of NaS had any discernible impact.

Another experiment assessed the homeostatic expansion of donor T cells in mice that were given sucrose but were unable to develop mature T cells or B cells. The growth of vital adaptive immune system cells was only prevented by sucralose.

Overall, results from numerous studies indicated that high sucralose exposure reduces T cell proliferation and differentiation.

Dr. Vousden, the senior author of the study, told that the team was shocked that “the effect was so evident across several mice models” due to sucralose’s poor absorption.

Sucralose did not appear to affect the activity of other immune cells, which shocked her team as well. “We were also startled to discover such a particular effect of sucralose on T-cells — none of the other sweeteners had this effect,” she said.

Effects of sucralose

Sucralose or NaS administration to mice for up to 12 weeks did not influence their dietary habits or body weight, according to the research. It also had no discernible impact on the mice’s fasting insulin levels or glucose tolerance.

Sucralose has been demonstrated to have an impact on the gut microbiota in certain studies, including one from 2008. But, in this most recent publication, researchers found “no consistent alteration in the bacterial species” in the mice given sucralose-treated stools.

The researchers also opted to investigate the medicinal potential of sucralose in the management of autoimmune diseases. They did this by administering sucralose to NOD (nonobese diabetic) mice.

According to Vousden, sucrose does not necessarily have a detrimental impact on the immune system. The findings suggest that the sweetener might one day be utilised therapeutically to treat autoimmune diseases, according to her.

The researchers treated mice that were engineered to be predisposed to type 1 diabetes, an autoimmune disorder that induces T cells to assault pancreatic cells, excessive dosages of the sweetener to test this notion in animals. Just approximately a third of the mice given the sweetener acquired diabetes after about 30 weeks; in contrast, all of the animals given simply water got the disease.

In the event that human studies reveal a similar outcome, according to Zani, he could imagine the sweetener being used in conjunction with more traditional immunosuppressive medications. As a result, doctors might be able to reduce the dosages of these medications. Walther believes that this line of enquiry is promising, particularly in light of the fact that sucralose is inexpensive to produce and would have less negative side effects.

long-term use of sucralose

In a 2018 study, Dr. Fabio Cominelli of Case Western Reserve University School of Medicine in Ohio discovered that sucralose consumption by mice may negatively affect the intestinal flora. Dr. Cominelli is the director of the Digestive Health Research Institute.

Dr. Cominelli, who was not involved in the current study, stated that he was unsure of the reason why the microbiome did not undergo significant changes as reported by the researchers.

He did, however, draw MNT’s attention to the fact that the rodent testing relied on doses of the sweetener that are far greater than what humans generally ingest, meaning that the article may not be relevant to scientists interested in the long-term effects of sucralose on humans.

REFERENCES:

For more details, kindly visit below.

Explore the warning signs of immune system problems.

Explore the warning signs of immune system problems.

It’s a lifesaver when your immune system is functioning properly. That may be excellent, but it is not faultless. This unique collection of cells, tissues, and organs occasionally behaves improperly.

With autoimmune illnesses, your immune system attacks your body unintentionally. Rheumatoid arthritis, Crohn’s disease, and a few thyroid diseases are examples of these types.

What is an autoimmune disease?

Normally, the immune system protects against viruses and germs. It sends out an army of fighter cells to attack these foreign invaders as soon as it detects them.

The immune system can typically distinguish between your own cells and foreign cells. When you have an autoimmune disease, your immune system misinterprets your skin or joints as alien tissues. Autoantibodies, which are proteins released by the body, assault healthy cells.

Certain autoimmune disorders only affect a single organ. The pancreas is harmed by type 1 diabetes. Some illnesses, such as lupus or systemic lupus erythematosus (SLE), can have a total body impact.

A brief description of some of the most prevalent autoimmune illnesses is given below.

Why does the immune system attack the body?

Clinicians are unsure of the precise aetiology of immune system malfunction. Nonetheless, some people are more likely than others to develop an autoimmune disease.

According to a 2014 study, women are more likely than males to develop autoimmune illnesses (6.4% of women versus 2.7% of men). A lot of times, the illness strikes women who are fertile (ages 15 to 44).

Some ethnic groups are more likely to develop specific autoimmune illnesses. For instance, lupus affects white individuals less than it does African Americans and Hispanics.

Many autoimmune conditions, including lupus and multiple sclerosis, run in families. Although not every family member will necessarily have the same illness, they all have a propensity for autoimmune diseases.

Researchers believe environmental factors like infections and exposure to chemicals or solvents may potentially play a role in the rise in the prevalence of autoimmune illnesses.

Another possible risk factor for developing an autoimmune illness is a “Western diet”. Consuming meals that are rich in fat, sugar, and processing is likely to contribute to inflammation, which may trigger an immunological response. But there is no proof of this.

SHORT VERDICT: The precise causation of autoimmune disorders is unknown. A number of factors may be at play, including genetics, nutrition, infections, and chemical exposure.

Your chance of contracting COVID-19 may increase if your immune system is compromised. If you have symptoms, make sure to get checked as soon as possible.

Common signs of a weak immune system

Remember that there are numerous additional reasons why these potential signals might appear. You should visit your doctor to find out what’s wrong with your health.

Cold hands

Your fingers, toes, ears, and nose may have a tougher time maintaining heat if your blood vessels are irritated. When exposed to cold, the skin in these places may turn white, then blue. The skin may turn red after the blood flow has resumed.

“Raynaud’s phenomenon,” as doctors refer to it. It can be brought on by immune system issues as well as by smoking, some prescription medications, and artery-related illnesses.

Dry Eyes

If you suffer from an autoimmune condition, your immune system is attacking your body rather than protecting it. Lupus and rheumatoid arthritis are two examples.

Dry eyes are a common symptom for those with autoimmune diseases. You can get a sand-like, grainy feeling in your eye. Astringent discharge, discomfort, redness, or blurred vision are some potential symptoms. Even when they are angry, some people find they are unable to cry.

Fatigue

Extreme fatigue similar to what you experience from the flu may indicate a problem with your body’s defences. Sleep probably won’t do any good. Your muscles or joints may also hurt. However, there may be a variety of different causes for your feelings.

Light Fever

Your immune system may be beginning to overwork itself if your body temperature is higher than usual. It may occur as a result of an impending infection or the beginning of an autoimmune disorder flare-up.

Headaches

Headaches can have an immune system component. Vasculitis, for instance, is the inflammation of a blood vessel brought on by an infection or an autoimmune disorder.

Rash

Your body’s first line of defence against pathogens is your skin. How it feels and looks may be an indication of how well your immune system is functioning.

Skin that is red, dry, and itchy is a typical sign of inflammation. The same goes for rashes that hurt or don’t go away. Lupus patients frequently develop a butterfly-shaped rash on their cheeks and nose.

Joint Pain

Your joints become sensitive to the touch when the lining inside them gets inflamed. It might affect more than one joint, and it may also be stiff or swollen. It can seem to be worse in the morning.

Patchy Hair Loss

The immune system can occasionally assault hair follicles. You can have a disorder called alopecia areata if you experience hair loss on your scalp, face, or other areas of your body. Hair breaking out in clumps or strands is another sign of lupus.

Continual Infections

Your body might not be able to effectively combat germs on its own if you need to take antibiotics more than twice per year (four times for kids).

Additional warning signs include persistent sinus infections, having more than four ear infections in a calendar year (for anybody older than 4), and recurring pneumonia.

Sun sensitivity

Photodermatitis, an allergic response to ultraviolet (UV) radiation, can occasionally occur in people with autoimmune diseases. After being in the sun, you can develop blisters, a rash, or scaly spots. Alternatively you can get nausea, a headache, or chills.

Numbness or Tingling in Your Feet and Hands

That might be entirely benign. Yet, in other circumstances it may indicate that your body is targeting the nerves that communicate with your muscles. For example, numbness that begins in the legs and spreads to the arms and chest may be a symptom of Guillain-Barre syndrome.

Acute inflammatory demyelinating polyneuropathy (AIDP), the demyelinating type of GBS, lasts for two to thirty days, whereas chronic inflammatory demyelinating polyneuropathy (CIDP) lasts longer. Longer-lasting is CIDP.

Difficulty swallowing

Your oesophagus, which transports food from your mouth to your stomach, may be enlarged or underdeveloped if you have trouble swallowing. Some individuals have a food-stuck sensation in their throat or chest. Those who swallow choke or gag. Your immune system could be one of the potential causes.

Unaccounted-for Weight Change

Even if your eating habits and exercise routine haven’t altered, you notice that you are putting on weight. Perhaps the number on your scale can fall without apparent cause. It’s possible that your thyroid gland has been harmed by an autoimmune disease as a result.

White Spots

Sometimes, melanocytes, the cells that produce colour in the skin, are targeted by the immune system. If so, your body will start to develop white patches of skin.

Your Skin or Eyes Are Turning Yellow

Jaundice, sometimes called biliary cirrhosis, is a condition where your immune system attacks and destroys healthy liver cells. This may result in autoimmune hepatitis, a disease.

Symptoms of autoimmune diseases

Several autoimmune illnesses have early signs and symptoms, including:

  • fatigue
  • stiff muscles
  • swell and erythema
  • minimal fever
  • difficulty concentrating
  • tingling and numbness in the hands and feet
  • hair fall
  • body rashes

Also, every disease may have a different set of symptoms. As an illustration, type 1 diabetes results in excessive thirst, weight loss, and exhaustion. IBD results in diarrhoea, bloating, and stomach pain.

Symptoms of autoimmune illnesses like psoriasis or RA can fluctuate. A flare-up is a time when symptoms are present. Remission refers to the time frame during which symptoms disappear.

VERDICT: Signs of an autoimmune disease may include weariness, muscle aches, swelling, and redness. With time, symptoms may appear and disappear.

REFERENCES:

For more details, kindly visit below.

Skipping breakfast may compromise the immune system.

Skipping breakfast may compromise the immune system.

Many health advantages of fasting have been reported. However, a recent mouse study raises the possibility that there may be a trade-off in the form of weakened immunity. The research discovered that during fasting, immune cells moved from the animals’ circulation to their bone marrow. Also, they surged back when eating resumed.

When food is scarce, hunger causes a hormonal stress response in the brain that may force the immune system to save resources. Although it hasn’t been proven, research suggests that habitually skipping breakfast may weaken a person’s immune system.

Although many people refer to breakfast as “the most important meal of the day,” scientific evidence on the consequences of skipping breakfast on health is still ambiguous.

It is widely acknowledged that breakfast is “the most essential meal of the day,”. However, scientific study on the consequences of skipping breakfast for your health has not yet reached a firm conclusion.

Contrary to popular belief, numerous studies have discovered that regular midday fasting. They are often known as “time-restricted feeding,” provides several health advantages. For instance, research indicates that calorie restriction and fasting are associated with a lower risk of age-related diseases such hypertension, atherosclerosis, obesity, and diabetes.

Yet, a recent investigation using mice raises the possibility that fasting has drawbacks. According to the study, animals who weren’t allowed to feed in the hours after they got up experienced a dramatic decline in the amount of circulating immune cells.

The study’s lead author, Filip Swirski, Ph.D., says there is growing recognition that fasting is healthy and that there is ample data supporting its advantages. He continues, “Our study offers a word of caution as it implies that there may potentially be a cost to fasting that carries a health risk.

How fasting affects immune cells?

Because they are nocturnal, mice spend the day dormant and only go scavenging at night. The researchers contrasted mice with unlimited access to food with mice with limited access to food in the hours after the onset of activity.

Monocytes, a type of immune cell, were found in lower concentrations in fasting mice bloodstream after only four hours. Monocytes are produced in the bone marrow and are typically seen scouring the body for infections. Moreover, the cells are involved in tissue healing and inflammation.

Further research by the researchers demonstrated that during fasting periods, immune cells returned from the bloodstream to the bone marrow. Yet as soon as feeding resumed, monocytes flowed back into the blood. This causes monocytosis, a condition in which there are abnormally large quantities of these immune cells.

According to Dr. Swirski, the study shows that, on the one hand, fasting reduces the amount of circulating monocytes. One may believe is a good thing because these cells are major components of inflammation”. However, the return of food causes a spike in the number of monocytes in the blood, which can be dangerous, he continues.

Fasting elicits a stress response in the brain

The relationship between the brain and monocytes when fasting was also investigated. Scientists discovered that being without food increases the brain’s stress response, which immediately causes a massive movement of monocytes from the blood into the bone marrow and back into the bloodstream after reintroducing food. According to the experts, this stress reaction to fasting also causes people to feel “hangry” (hungry and angry).

As food is reintroduced, a burst of monocytes returns to the circulation, which increases the hazards associated with fasting. According to the experts, fasting may have an impact on the body’s ability to fight against an infection in this way.

Fighting off infection

The effectiveness of mice’s capacity to fend off an illness was also evaluated by the researchers. They gave the mice a 24-hour fast, followed by a 4-hour feeding period, and then infected them with Pseudomonas aeruginosa, a bacterium that frequently causes pneumonia in hospitals.

The mice who fasted died earlier and in greater numbers than mice that had unlimited access to food throughout, possibly as a result of an increase in pulmonary inflammation.

It will be crucial to comprehend precisely how fasting affects monocytes because, as Dr. Swirski points out, they also play a significant role in diseases like heart disease and cancer. Further research by the researchers demonstrated that fasting altered the mice’s brains, which in turn caused the release of the stress hormone corticosterone.

The immune system called the immune cells back to the bone marrow in response to this stress signal. At times of resource constraint, this might aid the animals in resource conservation. The study demonstrates that the immunological and neurological systems interact, according to Dr. Swirski.

Costs and benefits of fasting

The benefits of fasting are well supported by evidence, according to Dr. Swirski. The latest study, he claimed, shows that there might nonetheless be a price. The balance between cost and benefit is what’s at risk in this situation, he claimed.

More measured kinds of fasting and controlled refeeding, as opposed to feasting after fasting, may be the key to striking a balance between the drawbacks and advantages, he suggested.

It is too soon to say whether studies done on mice, like the one mentioned above, have any relevance to people who skip breakfast or fast to lose weight. Dr. Swirski drew attention to several studies, however, which revealed that fasting also lowers blood monocyte levels in people.

REFERENCES:

  • https://www.medicalnewstoday.com/articles/skipping-breakfast-fasting-compromised-immune-system
  • https://www.mountsinai.org/about/newsroom/2023/skipping-breakfast-may-compromise-the-immune-system
  • https://www.thehealthsite.com/diseases-conditions/fasting-skipping-breakfast-may-negatively-affect-your-immunity-increase-heart-disease-risk-warn-experts-956795/

For more details, kinmdly visit below,.

Explore the body functions affected by Multiple Sclerosis.

Explore the body functions affected by Multiple Sclerosis.

Your nerves are impacted by multiple sclerosis, which manifests as symptoms including weariness, trouble walking, and speech problems. There is currently no cure, however there are a number of therapies that can help you manage the symptoms.

A persistent disorder affecting your central nervous system is called multiple sclerosis (MS). Your immune system destroys myelin, the covering that surrounds nerve fibres, when you have MS.

Inflammation and transient lesions are brought on by MS. Additionally, it may result in long-lasting lesions brought on by scar tissue, making it challenging for your brain to communicate with the rest of your body. MS cannot be cured, but symptoms can be controlled.

What is Multiple Sclerosis?

Although they are unsure of the actual cause of MS, researchers think it is an autoimmune condition that affects the central nervous system (CNS). The immune system assaults healthy tissue when a person has an autoimmune disease, just as it could attack a virus or bacteria.

In MS, inflammation results from the immune system attacking the myelin sheath, which covers and shields the nerve fibres. The nerves’ ability to swiftly and effectively conduct electrical signals is enabled by myelin.

“Scar tissue in numerous sites” is what multiple sclerosis signifies. Sclerosis, or a scar, results from the myelin sheath disappearing or being damaged in several places. These regions are also referred to by doctors as plaques or lesions. They mostly impact:

  • the cerebral stem
  • the cerebellum, which controls balance and movement coordination,
  • spinal cord
  • ocular nerves
  • Some brain areas have white matter.

Nerve fibres may rupture or suffer damage as more lesions appear. The electrical impulses from the brain do not reach the target nerve smoothly as a result. This implies that the body is unable to do some tasks.

Types of MS and stages

Multiple sclerosis comes in four different forms:

  • Clinically isolated syndrome (CIS): When someone experiences their first bout of MS symptoms, medical professionals frequently classify it as CIS. Multiple sclerosis does not always develop in CIS patients.
  • Relapsing-remitting MS (RRMS): It is the most prevalent type. Relapses or exacerbations, which are other terms for flare-ups of new or worsened symptoms, are common in people with RRMS. Following are times of remission (when symptoms stabilise or go away).
  • Primary progressive MS (PPMS): People with PPMS experience symptoms that slowly deteriorate over time without experiencing any relapses or remissions.
  • Secondary progressive MS (SPMS): People with RRMS who subsequently develop SPMS are commonly diagnosed with SPMS. Multiple sclerosis that is secondary-progressive causes ongoing nerve damage. Your symptoms get worse with time. You no longer have periods of remission following relapses or flares (when symptoms worsen), even if you may still have some of these (when symptoms stabilise or go away).

Causes of Multiple Sclerosis

Experts are still unsure about the precise cause of multiple sclerosis. To assist pinpoint the disease’s underlying causes, research is ongoing. Several things can cause MS, such as:

Exposure to specific viruses or bacteria: According to some studies, MS may develop later in life if a person is exposed to particular illnesses (such as the Epstein-Barr virus).

Your residence: Your chance of acquiring MS may be influenced by your environment. The prevalence of the disease is noticeably higher in some regions of the world than others. MS is more prevalent in regions that are farthest from the equator. That might be because the sun doesn’t shine as brightly in certain areas. A risk factor for MS development is reduced vitamin D levels in people who spend less time in the sun.

Multiple sclerosis is an autoimmune disease, which affects the way your immune system works. Researchers are trying to determine why immune cells in some people attack healthy cells inadvertently.

Gene mutations: Having an MS-afflicted family member does enhance your likelihood of developing the condition. However, it is still unknown precisely how and which genes contribute to the onset of multiple sclerosis.

Early signs and symptoms

MS symptoms can appear in any part of the body since the CNS, which regulates all bodily processes, is affected by the disease.

The most typical signs of MS include:

Weak muscles:

People may experience weak muscles as a result of inactivity or stimulation brought on by nerve injury.

One of the first signs of MS is Numbness and tingling, which can affect the face, body, arms, and legs and feel like pins and needles.

Lhermitte’s sign:

When a person moves their neck, they could feel an electric shock-like sensation; this is referred to as Lhermitte’s sign.

Bladder issues:

Urge incontinence, or the sudden or frequent need to urinate, can make it difficult for a person to empty their bladder. An early indication of MS is losing control of one’s bladder.

Bowel issues:

Fecal impaction brought on by constipation might result in bowel incontinence.

One of the most typical symptoms of MS is fatigue, which can make it difficult for a person to perform at work or at home.

Along with balance and coordination impairments, vertigo and dizziness are frequent ailments.

Sexual dysfunction:

Both sexes may become uninterested in having sex.

Muscle spasms and stiffness:

are early signs of MS. Painful muscle spasms, particularly those in the legs, can be brought on by damage to the nerve fibres in the spinal cord and brain.

Tremor:

Some MS patients may have uncontrollable trembling.

Having trouble seeing:

Some people may have double, blurry, or even complete loss of eyesight. One eye is typically affected at a time by this. When the eye moves, pain due to optic nerve inflammation may be experienced. Vision issues are a precursor to MS.

Changes in gait and mobility:

MS can alter a person’s gait owing to muscle weakness, issues with balance, weariness, and dizziness.

Depression and emotional changes:

Demyelination and brain nerve fibre loss can cause emotional alterations.

Memory and learning issues:

These can make it difficult to focus, prioritise, learn, plan, and multitask.

Pain:

MS patients frequently experience pain. While localised pain may be brought on by muscle stiffness or spasticity, neuropathic pain is directly related to MS.

Less frequent signs include:

  • headaches
  • loss of hearing
  • itching
  • breathing or respiratory issues
  • seizures
  • speaking issues
  • swallowing difficulties

Additionally, there is a greater chance of losing mobility, diminished activity, and urinary tract infections. A person’s career and social life may be impacted by these.

Risk factors for MS

There is still no known cause for MS. There are, however, a number of risk factors for MS development.

These risk elements consist of:

  • having a family member with MS
  • obesity
  • some infections
  • smoking
  • a few autoimmune diseases, including type 1 diabetes and rheumatoid arthritis

How is multiple sclerosis (MS) managed or treated?

MS presently has no known cure. The main goals of treatment are to control symptoms, lessen relapses (times when symptoms return), and reduce the disease’s course. Your detailed treatment programme can include:

  • Disease-modifying treatments (DMTs): The FDA has approved a number of drugs for the long-term treatment of multiple sclerosis (MS). These medications lessen relapses (also called flare-ups or attacks). They impede the spread of the illness. Additionally, they can stop the growth of new lesions on the spinal cord and brain.
  • Relapse prevention drugs: Your neurologist could advise a high dosage of corticosteroids if you experience a severe attack. The drug has a rapid anti-inflammatory effect. They mitigate harm to your nerve cells’ protective myelin coating.
  • Physical therapy: Multiple sclerosis might impair your physical capabilities. Maintaining your physical fitness and strength will assist your mobility.
  • Counseling for mental health: Managing a chronic illness can be emotionally taxing. Furthermore, MS might occasionally impair your mood and memory. A crucial component of treating the condition is working with a neuropsychologist or receiving other emotional assistance.

REFREENCES:

  • https://www.healthline.com/health/multiple-sclerosis
  • https://www.medicalnewstoday.com/articles/37556
  • https://my.clevelandclinic.org/health/diseases/17248-multiple-sclerosis
  • https://www.webmd.com/multiple-sclerosis/guide/what-is-multiple-sclerosis
  • https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269

For more details, kindly visit below.

Risk factors involved with Primary immunodeficiency disease

Risk factors involved with Primary immunodeficiency disease

Immune deficiencies make it difficult for your body to fight off illnesses and infections. You are more likely to contract viruses and bacterial illnesses if you have this kind of condition.

Disorders of the immune system can be either inherited or acquired. You are born with a congenital, or primary, disease. A secondary or acquired disorder is one that develops later in life. Congenital disorders are less frequent than acquired disorders.

The following organs are part of your immune system:

  • spleen
  • tonsils
  • blood marrow
  • lymph glands

Lymphocytes are processed and released by these organs. These are T cells and B cells, two types of white blood cells. Antigen-based intruders are fought by B and T lymphocytes. B cells release antibodies that are tailored to the illness your body has identified. Some T cells eliminate abnormal or alien cells.

Your B and T cells may need to defend themselves against various antigens, for instance:

  • bacteria
  • viruses
  • melanoma cells
  • parasites

Your body’s capacity to fight itself against these antigens is interfered with by an immunodeficiency condition.

What is a weak immune system?

You are immunocompromised if your immune system is impaired. This indicates that, compared to healthy individuals, your body is less capable of fending off viruses or diseases.

A weakened immune system can momentarily be brought on by treatments like anticancer therapies and radiation therapy, despite the fact that it is primarily brought on by certain illnesses, starvation, and specific genetic problems.

A stem cell or organ transplant may also momentarily impair your immune system.

Signs of an immunodeficiency disorder

Immunodeficiency illnesses come in many different shapes and sizes. Each illness has distinct symptoms that may be recurrent or persistent. There are, however, a few red flags that suggest your immune system may be malfunctioning.

Those who suffer from immunodeficiency disorders frequently get infections of certain illnesses, such as:

  • red eye
  • sinus problems
  • thrush
  • colds
  • persistent gum disease (gingivitis)
  • pneumonia
  • Candida infections

Immunodeficiency condition sufferers may experience chronic stomach pain as well as weight loss over time. Your doctor may do an immunodeficiency disorder test if you notice that you are susceptible to illnesses and viruses, and that you have trouble recovering from them.

Types of immunodeficiency disorders

When the immune system is not functioning as it should, an immune deficiency disease or disorder develops. It is referred to as primary immunodeficiency disease if you are born with a deficiency that has a hereditary aetiology. Primary immunodeficiency disorders number over 200.

Primary immunodeficiency disorders include, for example:

  • common variable immunodeficiency (CVID)
  • severe combined immunodeficiency (SCID), which is also known as alymphocytosis
  • chronic granulomatous disease (CGD)

When your body is weakened by an external factor, such as a chemical or virus, secondary immunodeficiency problems develop. A secondary immunodeficiency condition can result from the following:

  • a lot of burns
  • chemotherapy
  • radiation
  • diabetic nephropathy
  • malnutrition

Secondary immunodeficiency disorders include, for example:

  • AIDS
  • immune system malignancies, such as leukaemia
  • immune-complex diseases, like viral hepatitis
  • multiple myeloma (cancer of the plasma cells, which produce antibodies)

Causes of immunodeficiency disorders

Numerous primary immunodeficiency diseases are inherited and are acquired from either one or both parents. Many of these immune system flaws are brought on by issues with the DNA, which serves as the body’s blueprint for genetic construction.

More than 300 different primary immunodeficiency illnesses have been identified so far, and new ones are constantly being discovered. Based on whatever immune system component is impacted, they can be roughly divided into six groups:

  • Lack of B cells and antibodies
  • defects in T cells
  • a combined lack of B and T cells
  • flawed phagocytes
  • Deficits in the complement
  • Unknown (idiopathic)

Risk factors

A larger risk of acquiring primary immunodeficiency disorders in oneself exists in those with a family history of such conditions. An additional immunodeficiency condition can result from anything that impairs your immune system. As an illustration, exposure to HIV-infected bodily fluids or organ excision and replacement are both potential causes.

Additionally, ageing can impair your immune system. Some of the organs that make or process white blood cells decrease and perform less effectively as you age. Proteins are essential for maintaining immunity. Your immune system may become weakened if you don’t consume enough protein.

While you sleep, your body also generates proteins that aid in the body’s ability to fight infections. Because of this, getting too little sleep can weaken your immune system. Additionally, cancer and chemotherapy medications can lower your immunity.

Prevention of immunodeficiency disorders

There is no method to prevent primary immunological illnesses because they are brought on by genetic alterations. However, there are precautions you can do to avoid infections if you or your child has a compromised immune system:

  • Maintain proper hygiene. Use a light soap to wash your hands after using the restroom and before eating.
  • Maintain good oral hygiene. At least twice a day, brush your teeth.
  • Proper diet, An illness can be avoided with a healthy, balanced diet.
  • Be active physically. Your whole health depends on maintaining a healthy lifestyle. Find out what activities are suitable for you by asking your doctor.
  • Get adequate rest. Try to get the same amount of sleep each night and try to go to bed and wake up at the same time each day.
  • Stress management. According to certain research, stress may weaken your immune system. Massage, meditation, yoga, biofeedback, or hobbies can help you manage your stress. Figure out what works for you.
  • Prevent exposure. Avoid crowds and persons who have colds or other diseases.
  • Consult your doctor regarding vaccines. Learn which ones you ought to have.

REFERENCES:

AIDS: Important guide for this life threatening condition.

AIDS: Important guide for this life threatening condition.

What is AIDS?

HIV-positive individuals have the potential to acquire AIDS. It is HIV’s most advanced stage. However, merely having HIV does not guarantee that a person will get AIDS. CD4 cells die due to HIV. A healthy adult’s CD4 count typically ranges from 500 to 1,600 cells per cubic millimetre. AIDS will be declared in an HIV patient whose CD4 level is less than 200 cells per cubic millimetre.

A person with HIV may potentially be identified as having AIDS if they experience an opportunistic infection or malignancy that is uncommon in persons without HIV.

Pneumocystis jiroveci pneumonia is an example of an opportunistic illness that only affects people who are extremely immunocompromised, such as those with advanced HIV infection (AIDS).

If left untreated, HIV can develop into AIDS in ten years. Currently, there is no therapy for AIDS, and the life expectancy upon diagnosis is just approximately three years. dependable source If the individual contracts a serious opportunistic sickness, this could be cut short. However, antiretroviral medication therapy can stop the onset of AIDS.

If AIDS does arise, it indicates that the immune system is seriously damaged, or weak to the point where it can no longer effectively fight off most infections and diseases.

As a result, they are more susceptible to a variety of diseases, such as:

  • pneumonia
  • tuberculosis
  • a fungal infection of the mouth or throat known as oral thrush
  • the herpes virus cytomegalovirus (CMV)
  • A fungus in the brain causes cryptococcal meningitis.
  • Toxoplasmosis is a parasitic brain disease.
  • A disorder brought on by an intestinal parasite called cryptosporidiosis
  • malignancy, such as lymphoma and Kaposi sarcoma (KS)

It is not a direct consequence of the condition itself that untreated AIDS is associated with a shorter life expectancy. Instead, it’s a result of the illnesses and problems that come with having an immune system that has been compromised by AIDS.

Where did HIV come from?

A certain chimpanzee species in Central Africa is where humans first contracted HIV. According to studies, the HIV virus may have spread from chimpanzees to humans as early as the late 1800s.

Simian immunodeficiency virus is the name of the virus that affects chimpanzees. The likelihood is that HIV was spread to people when they killed these chimpanzees for food and came into touch with their diseased blood.

HIV progressively expanded over Africa over many years, then to other regions of the world. In the United States, the virus has been around since at least the mid- to late 1970s.

Symptoms of HIV

Acquired immunodeficiency syndrome (AIDS) is referred to. HIV, which has generally gone untreated for many years, weakens the immune system in people with this condition. The likelihood of developing AIDS is reduced if HIV is identified and treated with antiretroviral medication at an early stage.

When HIV is discovered too late or when a person knows they have HIV but doesn’t take their antiretroviral medicine regularly, they run the risk of developing AIDS. If they have an HIV strain that is resistant to (or does not react to) antiretroviral therapy, they may also go on to develop AIDS.

People with HIV may experience an earlier onset of AIDS without effective and continuous therapy. By then, the immune system has suffered significant damage and struggles to mount a defence against illness and infection.

Antiretroviral medication allows a person to retain a chronic HIV diagnosis without progressing to AIDS for many years.

Among the signs of AIDS are:

  • persistent fever
  • chronically enlarged lymph nodes, particularly in the groyne, neck, and armpits
  • persistent tiredness
  • morning sweats
  • black spots inside the mouth, nose, or eyelids or under the skin.
  • Anus lumps, lesions, or rashes of the skin, sores, spots, or lesions of the lips and tongue; genital lesions,
  • Chronic or recurring diarrhoea
  • quick loss of weight
  • neurological issues include memory loss, confusion, and difficulty focusing
  • both tension and despair

Antiretroviral therapy manages the infection and typically stops the development of AIDS. Treatment options exist for AIDS-related complications and other infections. The person’s specific needs must be taken into account when designing the treatment.

How is HIV transmitted?

HIV can be distributed in a variety of ways:

  • by having unprotected sex with an HIV-positive person. It spreads primarily in this manner.
  • lending each other a needle.
  • by coming into contact with an HIV-positive person’s blood.
  • During pregnancy, childbirth, or breastfeeding, from mother to kid.

You CANNOT obtain HIV via kissing, sharing food or beverages, or using the same fork or spoon since saliva (spit) is not how HIV is communicated. Additionally, HIV cannot be transmitted through hugging, holding hands, coughing, or sneezing. And a toilet seat cannot transmit HIV to you.

HIV infection was once spread through blood transfusions. However, it is now completely safe to give or receive blood in medical facilities. In addition to testing donated blood for HIV and other illnesses, doctors, hospitals, and blood donation facilities never reuse needles.

REFERENCES:

For more details, kindly visit below.